Related Experiment Video
Updated: Aug 29, 2026

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
Published on: February 6, 2015
Activating transcription factor 4 increases the cisplatin resistance of human cancer cell lines
Mizuho Tanabe1, Hiroto Izumi, Tomoko Ise
1Departments of Molecular Biology and. Surgery II, University of Occupational and Environmental Health, School of Medicine, Kitakyushu, Fukuoka, Japan.
Abstract:
Resistance to cisplatin is a major problem in the treatment of solid tumors. To investigate the determinants of cisplatin resistance, we have identified cisplatin-inducible genes by differential display of mRNA. One of the cisplatin-inducible genes was identified as activating transcription factor 4 (ATF4). Northern blot analysis demonstrated that expression of ATF4 is inducible at the transcriptional level. Its expression is also up-regulated in two cisplatin-resistant cell lines. We tested whether cellular levels of ATF4 are responsible for cisplatin sensitivity by examining 11 human lung cancer cell lines. Expression of ATF4 was found to correlate with cisplatin sensitivity (P = 0.01). We also evaluated the cisplatin sensitivity of two stable transfectants overexpressing ATF4. Both were less sensitive to cisplatin than the parental cells but equally sensitive to vincristine. Our findings suggest that levels of ATF4 expression could help to predict cisplatin sensitivity.
Insights
Activating transcription factor 4 (ATF4) expression correlates with cisplatin sensitivity in lung cancer. Higher ATF4 levels may predict reduced sensitivity to cisplatin chemotherapy, aiding treatment strategies.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Genetics
Background:
- Cisplatin resistance is a significant challenge in solid tumor treatment.
- Identifying molecular determinants of cisplatin resistance is crucial for improving therapeutic outcomes.
Purpose of the Study:
- To identify genes involved in cisplatin resistance.
- To investigate the role of activating transcription factor 4 (ATF4) in cisplatin sensitivity.
Main Methods:
- Differential display of mRNA to identify cisplatin-inducible genes.
- Northern blot analysis to assess ATF4 expression.
- Correlation analysis of ATF4 levels with cisplatin sensitivity in 11 human lung cancer cell lines.
- Overexpression studies in stable transfectants.
Main Results:
- Activating transcription factor 4 (ATF4) was identified as a cisplatin-inducible gene.
- ATF4 expression is transcriptionally regulated and upregulated in cisplatin-resistant cell lines.
- ATF4 expression levels significantly correlated with cisplatin sensitivity (P = 0.01).
- Overexpression of ATF4 reduced sensitivity to cisplatin but not vincristine.
Conclusions:
- Cellular levels of ATF4 are linked to cisplatin sensitivity.
- ATF4 expression may serve as a predictive biomarker for cisplatin response in lung cancer.
Related Concept Videos
Treatment Resistant Cancers
Induced Pluripotent Stem Cells
Somatic cells are...
Somatic to iPS Cell Reprogramming
Abnormal Proliferation
Combinatorial Gene Control
The expression of more than 30,000 genes is controlled by approximately 2000-3000 transcription factors. This is possible because a single transcription factor can recognize more than one regulatory sequence. The specificity in gene...
RNA Polymerase II Accessory Proteins
